Evidence map›Paper›PMID 37072503›Full record

Trial reportScientific reports2023

Randomized clinical trial on the clinical effects of a toothpaste containing extra virgin olive oil, xylitol, and betaine in gingivitis.

Alejandro Rodríguez-Agurto, Manuel Bravo, Antonio Magán-Fernandez, Ana López-Toruño, Ricardo Muñoz, Joaquín Ferrer, Francisco Mesa

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05635929 (Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. A Two Phases Study, Part of STOP OM PROJECT. Phase 2, Single Arm, Interventional, Longitudinal, Clinical Trial.), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05635929 narecruitingnot on this map

Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. A Two Phases Study, Part of STOP OM PROJECT. Phase 2, Single Arm, Interventional, Longitudinal, Clinical Trial.

TypeinterventionalSponsorMucosa Innovations, S.L.Ran2022 to 2027Enrolled63ConditionsOral Mucositis, Quality of Life, Mucositis, PainArmsXCM-OM118 Composition comprising olive oil, betaine and xylitol
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alejandro Rodríguez-AgurtoDepartment of Periodontics, School of Dentistry, University of Granada, Granada, Spain.
Manuel BravoDepartment of Preventive and Community Dentistry, University of Granada, Granada, Spain.
Antonio Magán-FernandezDepartment of Periodontics, School of Dentistry, University of Granada, Granada, Spain. amaganf@ugr.es.
Ana López-ToruñoDepartment of Periodontics, School of Dentistry, University of Granada, Granada, Spain.
Ricardo MuñozOdontólogo, Centro de Salud de Loja, Unidad de Salud Bucodental Distrito Metropolitano, Servicio Andaluz de Salud, Granada, Spain.
Joaquín FerrerOdontólogo, Centro de Salud de Huétor-Tajar, Unidad de Salud Bucodental Distrito Metropolitano, Servicio Andaluz de Salud, Granada, Spain.
Francisco MesaDepartment of Periodontics, School of Dentistry, University of Granada, Granada, Spain.
Universidad de Granada · ESAndalusian Health Service · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine the effects on gingival bleeding, dental biofilm, and salivary flow and pH in patients with gingivitis of using toothpaste with extra-virgin olive oil (EVOO), xylitol, and betaine in comparison to a placebo or commercial toothpaste. This controlled, double blinded, and multicenter randomized clinical trial included patients with gingivitis randomly assigned to one of three groups: test group (EVOO, xylitol, and betaine toothpaste), control group 1 (placebo toothpaste), or control group 2 (commercial toothpaste). Percentage supragingival biofilm and gingival bleeding were evaluated at baseline (T0), 2 months (T2), and 4 months (T4), measuring non-stimulated salivary flow and salivary pH. Comparisons were performed between and within groups. The final study sample comprised 20 in the test group, 21 in control group 1, and 20 in control group 2. In comparison to control group 1, the test group showed significantly greater decreases in gingival bleeding between T4 and T0 (p = 0.02) and in biofilm between T2 and T0 (p = 0.02) and between T4 and T0 (p = 0.01). In the test group, salivary flow significantly increased between T2 and T0 (p = 0.01), while pH alkalization was significantly greater between T4 and T0 versus control group 2 (p = 0.01) and close-to-significantly greater versus control group 1 (p = 0.06). The toothpaste with EVOO, xylitol, and betaine obtained the best outcomes in patients with gingivitis, who showed reductions in gingival bleeding and supragingival biofilm and an increase in pH at 4 months in comparison to a commercial toothpaste.

Indexed as

GingivitisToothpastesBetaineDental Plaque IndexDouble-Blind MethodHumansOlive OilXylitolBetaineOlive OilToothpastesXylitol

Identifiers

PMID37072503
PMCPMC10113385
OpenAlexW4366279897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.